ARID3B | AT rich interactive domain 3B (BRIGHT-like) | Transcription factors
| | | | | Mixed |
ARID4A | AT rich interactive domain 4A (RBP1-like) | Transcription factors
| | | | | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ATF2 | Activating transcription factor 2 | Enzymes Transcription factors
| | | | | Expressed in all |
ATF4 | Activating transcription factor 4 | Transcription factors
| | | | | Expressed in all |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Mixed |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CRAMP1L | Crm, cramped-like (Drosophila) | Transcription factors
| | | | | Expressed in all |
CREBZF | CREB/ATF bZIP transcription factor | Transcription factors
| | | | | Expressed in all |
CUX1 | Cut-like homeobox 1 | Cancer-related genes Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | Cancer-related genes Transcription factors
| | | | | Mixed |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ETS1 | V-ets avian erythroblastosis virus E26 oncogene homolog 1 | Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
ETV6 | Ets variant 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ETV7 | Ets variant 7 | Transcription factors
| | | | | Mixed |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
FOSL2 | FOS-like antigen 2 | Transcription factors
| | | | | Expressed in all |
FOXP1 | Forkhead box P1 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
FOXP4 | Forkhead box P4 | Transcription factors
| | | | | Expressed in all |
GATAD2A | GATA zinc finger domain containing 2A | Plasma proteins Transcription factors
| | | | | Expressed in all |
GRHL2 | Grainyhead-like 2 (Drosophila) | Disease related genes Transcription factors
| | | | | Mixed |
GTF3A | General transcription factor IIIA | Transcription factors
| | | | | Expressed in all |
HOXB13 | Homeobox B13 | Transcription factors
| | | | | Group enriched |
HSF1 | Heat shock transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | Transcription factors
| | | | | Tissue enhanced |
IRF2 | Interferon regulatory factor 2 | Transcription factors
| | | | | Expressed in all |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
IRF7 | Interferon regulatory factor 7 | Transcription factors
| | | | | Expressed in all |
IRF8 | Interferon regulatory factor 8 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
LEF1 | Lymphoid enhancer-binding factor 1 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
MEF2D | Myocyte enhancer factor 2D | Transcription factors
| | | | | Expressed in all |
MIER1 | Mesoderm induction early response 1, transcriptional regulator | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MITF | Microphthalmia-associated transcription factor | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
MTA1 | Metastasis associated 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MTA2 | Metastasis associated 1 family, member 2 | Plasma proteins Transcription factors
| | | | | Expressed in all |
NFATC1 | Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | Transcription factors
| | | | | Expressed in all |
NFIA | Nuclear factor I/A | Transcription factors
| | | | | Expressed in all |
NFIC | Nuclear factor I/C (CCAAT-binding transcription factor) | Transcription factors
| | | | | Expressed in all |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
NFKB2 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
NFKBIE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | Cancer-related genes Transcription factors
| | | | | Mixed |
NONO | Non-POU domain containing, octamer-binding | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
PHF5A | PHD finger protein 5A | Transcription factors
| | | | | Expressed in all |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
RFXANK | Regulatory factor X-associated ankyrin-containing protein | Disease related genes Transcription factors
| | | | | Expressed in all |